Abstract
Virus infection was conventionally considered to cause myocarditis, which resulted in development of dilated cardiomyopathy. Recent studies suggest that hepatitis C virus (HCV) is involved in the development of dilated cardiomyopathy, hypertrophic cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy in addition to myocarditis. Furthermore, left ventricular aneurysm represents the same morbid state not only after myocardial infarction but also after myocarditis. There were wide variations in the frequency of detection of HCV genomes in cardiomyopathies in different regions or in different populations. Major histocompatibility complex class II genes may play a role in the susceptibility to HCV infection, and may influence the development of different phenotypes of cardiomyopathies. If it is the fact that the myocardial damage is caused by HCV, it might be expected that interferon (IFN) treatment would be useful for its treatment. Patients receiving IFN treatment of hepatitis were screened by thallium myocardial scintigraphy, and an abnormality was discovered in half of patients. Treatment with IFN resulted in disappearance of the image abnormality. It has thus been suggested that mild myocarditis and myocardial damage may be cured with IFN. We have recently found that high concentrations of circulating cardiac troponin T are a specific marker of cardiac involvement in HCV infection. By measuring cardiac troponin T in patients with HCV infection, the prevalence of cardiac involvement in hepatitis C virus infection will be clarified. We are proposing a collaborative work on global network on myocarditis/cardiomyopathies due to HCV infection.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Human Leukocyte Antigen
- Major Histocompatibility Complex Class
- Dilate Cardiomyopathy
- Hypertrophic Cardiomyopathy
- Cardiac Troponin
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Abelmann WH, Lorell BH (1989) The Challenge of cardiomyopathy. J Am Coll Cardiol 13:1219–1239
Aikawa T, Kojima M, Onishi H, Tamura R, Fukuda S, Suzuki T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M (1996) HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C. J Med Virol 49:274–278
Alric L, Fort M, Izopet J, Vinel JP, Charlet JP, Selves J, Puel J, Pascal JP, Duffaut M, Abbal M (1997) Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 113:1675–1681
Beld M, Habibuw MR, Rebers S PH, Boom R, Reesink HW (2000) Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening system. Transfusion 40:575–579
Caforio A LP, Stewart JT, McKenna W J (1990) Idiopathic dilated cardiomyopathy. Br Med J 300:890–891
Cohen J (1999) The scientific challenge of hepatitis C. Science 285:26–30
Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson P T (1998) Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol 29:207–213
Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343:1388–1398
Higuchi M, Tanaka E, Kiyosawa K (2002) Epidemiology and clinical aspects on hepatitis C. Jpn J Infect Dis 55:69–77
Ishizaka N, Ishizaka Y, Takahashi E, Tooda E, Hashimoto H, Nagai R, Yamakoda M (2002) Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 359:133–135
Johnson RA, Palacios I (1982) Dilated cardiomyopathies of the adult. N Engl J Med 307:1119–1126
Kawai C, Matsumori A, Fujiwara H (1987) Myocarditis and dilated cardiomyopathy. Annu Rev Med 38:221–239
Kawano H, Kawai S, Nishijo T, Shirai T, Inagaki Y, Okada R (1994) An autopsy case of hypertrophic cardiomyopathy with pathological findings suggesting chronic myocarditis. Jpn Heart J 35:95–105
Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, Kaneshige T, Tatsumi T, Ito A, Mochizuki K, Sasaki Y, Kasahara A, Hori M (1998) Influence of HLA haplotypes on the clinical coursed of individuals infected with hepatitis C virus. Hepatology 27:240–244
Liu PP, Mason JW (2001) Advances in the understanding of myocarditis. Circulation 140:1076–1082
Matsumori A (1993) Animal models: pathological findings and therapeutic considerations. In: Banatvala JE, Edward A (eds) Viral infection of the heart. Edward Arnold, London, pp 110–137
Matsumori A (1997) Molecular and immune mechanisms in the pathogenesis of cardiomyopathy. Jpn Circ J 61:275–291
Matsumori A (2001) Myocardial diseases, nephritis, and vasculitis associated with hepatitis virus. Intern Med 40:78–79
Matsumori A (2003) Introductory chapter. In: Matsumori A (ed) Cardiomyopathies and heart failure. Biomolecular, infectious and immune mechanisms. Kluwer Academic Publishers, Boston, pp 1–15
Matsumori A (2005) Hepatitis C virus infection and cardiomypathies. Circ Res 96:144–147
Matsumori A, Kawai C (1982a) An animal model of congestive (dilated) cardiomyopathy: dilation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation 66:377–380
Matsumori A, Kawai C (1982b) An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice. Circulation 65:1230–1235
Matsumori A, Kawai C, Wakabayashi A, Terasaki PI, Park MS, Sakurami T, Ueno Y (1981) HLA-DRW4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy. Am Heart J 101:14–16
Matsumori A, Matoba Y, Sasayama S (1995) Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 92:2519–2525
Matsumori A, Matoba Y, Nishio R, Ono K, Sasayama S (1996) Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 222:678–682
Matsumori A, Ohashi N, Hasegawa K, Sasayama S, Eto T, Imaizumi T, Izumi T, Kawamura K, Kawana M, Kimura A, Kitabatake A, Matsuzaki M, Nagai R, Tanaka H, Horie M, Hori M, Inoko H, Seko Y, Sekiguchi M, Shimotohno K, Sugishita Y, Takeda N, Takihara T, Tanaka M, Tokuhisa T, Toyo-oka T, Yokoyama M (1998a) Hepatitis C virus infection and heart disease. A multicenter study in Japan. Jpn Circ J 62:389–391
Matsumori A, Ohashi N, Sasayama S (1998b) Hepatitis C virus infection and hypertrophic cardiomyopathy. Ann Intern Med 129:749–750
Matsumori A, Ohashi N, Nishio R, Kakio T, Hara M, Furukawa Y, Ono K, Shioi T, Sasayama S (1999) Apical hypertrophic cardiomyopathy and hepatitis C virus infection. Jpn Circ J 63:433–438
Matsumori A, Yutani C, Ikeda Y, Kawai S, Sasayama S (2000) Hepatitic C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest 80:1137–1142
Matsumori A, Furukawa Y, Hasegawa K, Sato K, Nakagawa H, Morikawa Y, Miura K, Ohno Y, Tamakoshi A, Inaba Y, Sasayama S (2002) Epidemiologic and clinical characteristics of cardiomyopathis in Japan-results from nationwide surveys. Circ J 66:323–336
Matsumori A, Ohashi N, Ito H, Furukawa Y, Hasegawa K, Sasayama S, Naruse T, et al. (2003) Genes of the major histocompatibility complex class II influence the phenotype of cardiomyopathies associated with hepatitis C virus infection. In: Matsumori A (ed) Cardiomyopathies and heart failure. Kluwer Academic Publishers, Boston, pp 515–521
Miura K, Nakagawa H, Morikawa Y, Sasayama S, Matsumori A, Hasegawa K, Ohno Y, Tamakoshi A, Kawamura T, Inaba Y (2002) Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey. Heart 87:126–130
Nakamura K, Matsumori A, Kusano K, Banba K, Taniyama M, Nakamura Y, Morita H, Matsubara H, Yamanari H, Ohe T (2000) Hepatitis C virus infection in a patient with dermatomyositis and left ventricular dysfunction. Jpn Circ J 64:617–618
Nishi H, Koga Y, Koyanagi T, Harada H, Imaizumi T, Toshima H, Sasazuki T, Kimura A (1995) DNA Typing of HLA class II genes in Japanese patients with dilated cardiomyopathy. J Mol Cell Cardiol 27:2385–2392
Okabe M, Fukuda K, Arakawa K, Kikuchi M (1997) Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation 96:22–24
Olinde KD, O’Connell JB (1994) Inflammatory heart disease: pathogenesis, clinical manifestation, and treatment of myocarditis. Annu Rev Med 45:481–490
Ooyake N, Kuzuo H, Hirano Y, Shimada T, Matsumori A (1999) Myocardial injury induced by hepatitis C virus and interferon therapy (abstract). Presented at the 96th Annual Scientific Meeting of the Japanese Society of Internal Medicine, Tokyo
Richardson P, Mckenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842
Sato Y, Takatsu Y, Yamada T, Kataoka K, Taniguchi R, Mimura R, Sasayama S, Matsumori A (2000) Interferon treatment for dilated cardiomyopathy and striated myopathy associated with hepatitis C virus infection based on serial measurements of serum concentration of cardiac troponin T. Jpn Circ J 64:321–324
Sato Y, Yamada T, Taniguchi R, Nagai K, Makiyama T, Okada H, Kataoka K, Ito H, Matsumori A, Sasayama S, Takatsu Y (2001) Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 103:369–374
Takeda A, Sakata A, Takeda N (1999) Detection of hepatitis C virus RNA in the hearts of patients with hepatogenic cardiomyopathy. Mol Cell Biochem 195:257–261
Teragaki M, Nishiguchi S, Takeuchi K, Yoshiyama M, Akioka K, Yoshikawa J (2003) Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathy. Heart Vessels 18:167–170
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Matsumori, A. (2006). Role of Hepatitis C Virus in Cardiomyopathies. In: Schultheiss, H.P., Kapp, J.F., Grötzbach, G. (eds) Chronic Viral and Inflammatory Cardiomyopathy. Ernst Schering Research Foundation Workshop, vol 55. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-30822-9_7
Download citation
DOI: https://doi.org/10.1007/3-540-30822-9_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23971-0
Online ISBN: 978-3-540-30822-5
eBook Packages: MedicineMedicine (R0)